Inspire Investing LLC Buys Shares of 3,193 Axon Enterprise, Inc $AXON

Inspire Investing LLC purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,193 shares of the biotechnology company’s stock, valued at approximately $2,291,000.

A number of other institutional investors have also modified their holdings of AXON. Brighton Jones LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at approximately $480,000. Axiom Investors LLC DE purchased a new stake in shares of Axon Enterprise during the 1st quarter valued at $93,088,000. CreativeOne Wealth LLC boosted its position in shares of Axon Enterprise by 9.9% in the 1st quarter. CreativeOne Wealth LLC now owns 4,748 shares of the biotechnology company’s stock worth $2,497,000 after purchasing an additional 429 shares in the last quarter. Ieq Capital LLC boosted its position in shares of Axon Enterprise by 7.0% in the 1st quarter. Ieq Capital LLC now owns 3,368 shares of the biotechnology company’s stock worth $1,771,000 after purchasing an additional 219 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. AG grew its stake in Axon Enterprise by 28.1% during the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 7,842 shares of the biotechnology company’s stock worth $4,124,000 after buying an additional 1,719 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the completion of the transaction, the president owned 249,502 shares in the company, valued at approximately $137,874,805.20. This trade represents a 7.42% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Brittany Bagley sold 2,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $580.00, for a total value of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares in the company, valued at $60,030,580. The trade was a 1.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 65,540 shares of company stock worth $39,201,438 in the last three months. Company insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on AXON shares. Royal Bank Of Canada assumed coverage on Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target for the company. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Needham & Company LLC reissued a “buy” rating and set a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Finally, Barclays cut their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research note on Thursday, November 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $802.71.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $591.15 on Friday. Axon Enterprise, Inc has a twelve month low of $469.24 and a twelve month high of $885.91. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The company has a market cap of $46.65 billion, a PE ratio of 187.07, a price-to-earnings-growth ratio of 135.77 and a beta of 1.40. The company’s 50 day moving average is $601.45 and its 200 day moving average is $702.84.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The business had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. During the same quarter in the previous year, the company earned $1.45 EPS. The firm’s revenue was up 30.6% compared to the same quarter last year. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.